NVST

Envista Holdings Corp NYSE

Healthcare ·Medical - Equipment & Services ·US · envistaco.com

$25.81

Mkt Cap $4.2B

52w Low $16.29 67.4% of range 52w High $30.42

50d MA $26.74 200d MA $22.87

P/E (TTM) 94.0x

EV/EBITDA 12.1x

P/B 1.4x

Debt/Equity 0.6x

ROE 1.5%

P/FCF 15.8x

RSI (14) —

ATR (14) —

Beta 0.98

50d MA $26.74

200d MA $22.87

Avg Volume 2.8M

About

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Speci…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 5, 2026	AMC	0.32	0.38	+18.8%	24.71	+13.0%	+17.8%	+18.8%	+22.1%	+22.5%	+16.4%	+8.1%	—
Oct 29, 2025	AMC	0.27	0.32	+18.5%	19.98	+3.1%	+0.8%	+1.9%	+0.6%	+0.9%	+0.9%	+4.6%	—
Jul 31, 2025	AMC	0.24	0.26	+8.3%	18.89	+7.1%	+10.3%	+8.4%	+6.2%	+4.3%	+6.4%	+9.7%	—
May 1, 2025	AMC	0.20	0.24	+20.0%	16.34	+4.7%	+4.0%	+3.9%	+0.3%	+3.1%	+8.8%	+10.8%	—
Feb 5, 2025	AMC	0.23	0.24	+4.3%	20.57	+9.2%	+5.9%	+3.3%	+3.2%	+2.2%	+1.4%	-10.4%	—
Oct 30, 2024	AMC	0.09	0.12	+33.3%	19.23	+14.4%	+9.0%	+8.9%	+10.7%	+9.7%	+13.8%	+15.9%	—
Aug 7, 2024	AMC	0.27	0.11	-59.3%	15.30	-0.5%	+7.8%	+5.8%	+6.0%	+11.0%	+13.1%	+14.0%	—
May 1, 2024	AMC	0.31	0.26	-16.1%	19.75	-7.3%	+0.3%	-3.8%	-3.5%	-3.8%	-4.7%	-2.0%	—
Feb 7, 2024	AMC	0.33	0.29	-12.1%	24.24	-9.2%	-7.4%	-9.5%	-5.9%	-9.7%	-8.7%	-12.4%	—
Nov 1, 2023	AMC	0.46	0.43	-6.5%	22.99	-11.9%	-7.6%	-3.9%	-7.2%	-6.7%	-5.7%	+4.0%	—
Aug 2, 2023	AMC	0.41	0.43	+4.9%	33.92	+1.7%	+1.0%	-0.8%	+3.0%	+1.5%	-1.7%	-4.5%	—
May 3, 2023	AMC	0.41	0.38	-7.3%	37.64	-13.5%	-6.9%	-6.1%	-7.5%	-8.3%	-9.7%	-12.4%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 24	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$27.04	$27.23	+0.7%	-0.9%	-1.0%	-2.0%	-4.2%	-4.1%
Apr 8	Evercore ISI	Maintains	Outperform → Outperform	—	$25.29	$26.68	+5.5%	+5.4%	+5.5%	+4.3%	+6.4%	+8.3%
Feb 11	Barclays	Maintains	Overweight → Overweight	—	$30.17	$30.22	+0.2%	+0.3%	-4.6%	-4.0%	-7.0%	-5.5%
Feb 10	Mizuho	Maintains	Neutral → Neutral	—	$29.36	$29.53	+0.6%	+2.8%	+3.1%	-2.0%	-1.3%	-4.4%
Feb 6	Piper Sandler	Maintains	Neutral → Neutral	—	$24.71	$27.91	+13.0%	+17.8%	+18.8%	+22.1%	+22.5%	+16.4%
Feb 6	JP Morgan	Maintains	Neutral → Neutral	—	$24.71	$27.91	+13.0%	+17.8%	+18.8%	+22.1%	+22.5%	+16.4%
Feb 6	Stifel	Maintains	Buy → Buy	—	$24.71	$27.91	+13.0%	+17.8%	+18.8%	+22.1%	+22.5%	+16.4%
Feb 6	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$24.71	$27.91	+13.0%	+17.8%	+18.8%	+22.1%	+22.5%	+16.4%
Feb 4	Stifel	Maintains	Buy → Buy	—	$22.91	$23.26	+1.5%	+3.3%	+7.9%	+27.0%	+28.2%	+31.7%
Feb 3	UBS	Maintains	Neutral → Neutral	—	$23.26	$23.36	+0.4%	-1.5%	+1.7%	+6.2%	+25.1%	+26.2%
Jan 30	Piper Sandler	Maintains	Neutral → Neutral	—	$23.39	$23.33	-0.3%	+0.3%	-0.6%	-2.1%	+1.2%	+5.6%
Jan 20	Mizuho	Upgrade	Underperform → Neutral	—	$25.24	$25.23	-0.0%	-3.6%	-2.3%	-3.3%	-5.5%	-4.7%
Dec 16	JP Morgan	Maintains	Neutral → Neutral	—	$22.06	$22.01	-0.2%	-0.7%	-1.0%	+0.9%	+1.0%	+1.7%
Aug 1	Mizuho	Maintains	Underperform → Underperform	—	$18.89	$20.24	+7.1%	+10.3%	+8.4%	+6.2%	+4.3%	+6.4%
Aug 1	Piper Sandler	Maintains	Neutral → Neutral	—	$18.89	$20.24	+7.1%	+10.3%	+8.4%	+6.2%	+4.3%	+6.4%
Aug 1	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$18.89	$20.24	+7.1%	+10.3%	+8.4%	+6.2%	+4.3%	+6.4%
Aug 1	Stifel	Maintains	Buy → Buy	—	$18.89	$20.24	+7.1%	+10.3%	+8.4%	+6.2%	+4.3%	+6.4%
Aug 1	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$18.89	$20.24	+7.1%	+10.3%	+8.4%	+6.2%	+4.3%	+6.4%
Jul 29	UBS	Maintains	Neutral → Neutral	—	$20.74	$20.79	+0.2%	-2.1%	-3.8%	-8.9%	+0.4%	-1.3%
Jul 9	Evercore ISI	Maintains	Outperform → Outperform	—	$20.15	$20.29	+0.7%	+1.1%	+2.8%	+0.2%	-0.6%	-1.7%
May 27	Baird	Upgrade	Neutral → Outperform	—	$16.72	$17.03	+1.9%	+7.7%	+10.8%	+10.4%	+9.3%	+8.3%
May 5	UBS	Maintains	Neutral → Neutral	—	$16.99	$16.78	-1.2%	-0.1%	-3.5%	-0.9%	+4.6%	+3.5%
May 2	Baird	Maintains	Neutral → Neutral	—	$16.34	$17.10	+4.7%	+4.0%	+3.9%	+0.3%	+3.1%	+8.8%
Apr 30	Piper Sandler	Maintains	Neutral → Neutral	—	$16.20	$15.71	-3.0%	-0.7%	+0.9%	+4.9%	+4.8%	+1.2%
Apr 29	BofA Securities	Maintains	Buy → Buy	—	$15.96	$15.95	-0.1%	+1.5%	+0.8%	+2.4%	+6.5%	+6.3%
Mar 10	UBS	Maintains	Neutral → Neutral	—	$18.43	$18.18	-1.4%	-5.0%	-7.1%	-9.2%	-11.8%	-9.7%
Mar 6	JP Morgan	Maintains	Neutral → Neutral	—	$18.24	$17.88	-2.0%	-2.2%	+1.0%	-4.0%	-6.1%	-8.2%
Mar 6	Needham	Maintains	Hold → Hold	—	$18.24	$17.88	-2.0%	-2.2%	+1.0%	-4.0%	-6.1%	-8.2%
Mar 6	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$18.24	$17.88	-2.0%	-2.2%	+1.0%	-4.0%	-6.1%	-8.2%
Feb 25	Needham	Maintains	Hold → Hold	—	$21.39	$21.38	-0.0%	-3.4%	-3.1%	-7.2%	-6.6%	-11.1%
Feb 6	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$20.57	$22.47	+9.2%	+5.9%	+3.3%	+3.2%	+2.2%	+1.4%
Feb 6	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$20.57	$22.47	+9.2%	+5.9%	+3.3%	+3.2%	+2.2%	+1.4%
Feb 6	Baird	Maintains	Neutral → Neutral	—	$20.57	$22.47	+9.2%	+5.9%	+3.3%	+3.2%	+2.2%	+1.4%
Feb 6	Needham	Maintains	Hold → Hold	—	$20.57	$22.47	+9.2%	+5.9%	+3.3%	+3.2%	+2.2%	+1.4%
Feb 3	Piper Sandler	Maintains	Neutral → Neutral	—	$20.52	$20.03	-2.4%	-2.4%	-1.9%	+0.2%	+6.2%	+3.6%
Jan 23	Jefferies	Maintains	Hold → Hold	—	$21.05	$21.34	+1.4%	+1.2%	+1.9%	+2.6%	+3.4%	+1.5%
Oct 31	Leerink Partners	Upgrade	Underperform → Market Perform	—	$19.23	$22.00	+14.4%	+9.0%	+8.9%	+10.7%	+9.7%	+13.8%
Oct 31	Baird	Maintains	Neutral → Neutral	—	$19.23	$22.00	+14.4%	+9.0%	+8.9%	+10.7%	+9.7%	+13.8%
Oct 31	Piper Sandler	Maintains	Neutral → Neutral	—	$19.23	$22.00	+14.4%	+9.0%	+8.9%	+10.7%	+9.7%	+13.8%
Oct 23	Stifel	Maintains	Buy → Buy	—	$18.66	$18.59	-0.4%	+2.3%	+1.9%	+1.2%	+3.1%	+0.7%
Sep 23	Evercore ISI	Maintains	Outperform → Outperform	—	$19.00	$19.60	+3.2%	+0.3%	-0.8%	-1.9%	+1.3%	+4.0%
Aug 8	Evercore ISI	Maintains	Outperform → Outperform	—	$15.30	$15.23	-0.5%	+7.8%	+5.8%	+6.0%	+11.0%	+13.1%
Aug 8	BofA Securities	Maintains	Buy → Buy	—	$15.30	$15.23	-0.5%	+7.8%	+5.8%	+6.0%	+11.0%	+13.1%
Aug 8	JP Morgan	Downgrade	Overweight → Neutral	—	$15.30	$15.23	-0.5%	+7.8%	+5.8%	+6.0%	+11.0%	+13.1%
Jul 30	Stifel	Maintains	Buy → Buy	—	$16.42	$16.12	-1.8%	+2.9%	+4.0%	+3.1%	+1.5%	-4.0%
Jul 30	Piper Sandler	Maintains	Neutral → Neutral	—	$16.42	$16.12	-1.8%	+2.9%	+4.0%	+3.1%	+1.5%	-4.0%
Jul 22	Baird	Maintains	Neutral → Neutral	—	$16.57	$16.39	-1.1%	-1.5%	-1.9%	-1.7%	-2.8%	-1.6%
Jun 25	Evercore ISI	Maintains	Outperform → Outperform	—	$16.93	$16.77	-0.9%	-5.5%	-2.5%	-2.7%	-1.8%	-4.8%
May 3	Goldman Sachs	Maintains	Sell → Sell	—	$19.81	$20.28	+2.4%	-4.1%	-3.8%	-4.1%	-4.9%	-2.7%
May 2	Baird	Maintains	Neutral → Neutral	—	$19.75	$18.31	-7.3%	+0.3%	-3.8%	-3.5%	-3.8%	-4.7%

Recent Filings

8-K · 7.01 ! Medium

Envista Holdings Corporation Common stock, $0.01 par value per share -- 8-K 7.01: Regulation FD Disclosure

Envista Holdings will present fourth-quarter 2025 financial results via conference call using a slide deck available on its investor website for stakeholder review.

Feb 5

Data updated apr 26, 2026 4:21pm · Source: massive.com